Tania Brandstoetter

Vienna, 1210, Austria

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications

Preserved bevacizumab (Avastin®) eye drops for application in multidose containers - an in-vitro characterisation.

Preserved bevacizumab (Avastin®) eye drops for application in multidose containers - an in-vitro characterisation.

Journal: BMC veterinary research
Published: March 23, 2023

SBNO2 is a critical mediator of STAT3-driven hematological malignancies.

SBNO2 is a critical mediator of STAT3-driven hematological malignancies.

Journal: Blood
Published: September 20, 2022

Oncogenic TYK2 P760L kinase is effectively targeted by combinatorial TYK2, mTOR and CDK4/6 kinase blockade.

Oncogenic TYK2 P760L kinase is effectively targeted by combinatorial TYK2, mTOR and CDK4/6 kinase blockade.

Journal: Haematologica
Published: September 07, 2021

A STAT5B-CD9 axis determines self-renewal in hematopoietic and leukemic stem cells.

A STAT5B-CD9 axis determines self-renewal in hematopoietic and leukemic stem cells.

Journal: Blood
Published: January 25, 2021

Characterization of p190-Bcr-Abl chronic myeloid leukemia reveals specific signaling pathways and therapeutic targets.

Characterization of p190-Bcr-Abl chronic myeloid leukemia reveals specific signaling pathways and therapeutic targets.

Journal: Leukemia
Published: July 27, 2020

A robust approach for the generation of functional hematopoietic progenitor cell lines to model leukemic transformation.

A robust approach for the generation of functional hematopoietic progenitor cell lines to model leukemic transformation.

Journal: Blood advances
Published: July 23, 2020

Inducible deletion of CDK4 and CDK6 - deciphering CDK4/6 inhibitor effects in the hematopoietic system.

Inducible deletion of CDK4 and CDK6 - deciphering CDK4/6 inhibitor effects in the hematopoietic system.

Journal: Haematologica
Published: April 22, 2020

Selective inhibition of STAT3 signaling using monobodies targeting the coiled-coil and N-terminal domains.

Selective inhibition of STAT3 signaling using monobodies targeting the coiled-coil and N-terminal domains.

Journal: Nature communications
Published: February 07, 2020

CDK6 is an essential direct target of NUP98 fusion proteins in acute myeloid leukemia.

CDK6 is an essential direct target of NUP98 fusion proteins in acute myeloid leukemia.

Journal: Blood
Published: September 10, 2019
Showing 1-9 of 9

Last Updated: 09/26/2026